AI News NQ Analysis

Craif's Urinary Cancer Test 'miSignal Scan' Introduced at JA Kanagawa Prefectural Welfare Federation Health and Welfare Centers

NQ Score 81/100
N1 Content Completeness 9

AI Summary (NQ-processed)

Bio-AI startup Craif announces the introduction of its urinary cancer test 'miSignal Scan' at JA Kanagawa Health Centers, enabling non-invasive early cancer detection for local residents.

AI Analysis

Frequently Asked Questions

Q: What is MySignal Scan?
A: It is a non-invasive test that uses AI to analyze microRNA in urine to evaluate the risk of 10 types of cancer, including pancreatic cancer, from stage 1.
Q: Where can I take this test?
A: It is available at places like the JA Health Management Center in Atsugi and Sagamihara, operated by JA Kanagawa Prefecture Health Federation.
Q: Is this a medical procedure (diagnosis)?
A: It is not a medical device or diagnostic procedure, but a statistical risk assessment. Even if the risk is low, it does not guarantee the absence of cancer.